GLYZORLLY-60M
-and-Metformin-Hydrochloride-(Sustained-Release)-Tablets.jpg "GLYZORLLY-60M")
Gliclazide (Modified Release) and Metformin Hydrochloride (Sustained Release) Tablets
Brand :- GLYZORLLY-60M
Pack Size : 10X10
Pack Type : B/P
Composition :
GLICLAZIDE 60MG + METFORMIN HYDROCHLORIDE 500MG TABLETS
Description :
GLYZORLLY-60M Tablets contain Gliclazide 60 mg (Modified Release) and Metformin Hydrochloride 500 mg (Sustained Release), a combination used for the management of type 2 diabetes mellitus. Gliclazide helps stimulate insulin secretion from the pancreas to reduce blood sugar levels, while Metformin decreases glucose production in the liver and improves insulin sensitivity. The modified and sustained release formulation provides gradual drug release for long-lasting glycemic control, helping maintain stable blood glucose levels and supporting overall metabolic health when used under medical supervision.
Products
-&-Voglibose-0.3-mg-Tablets.jpg "GLYZORLLY-MV 0.3")
-&-Voglibose-0.2-mg-Tablets.jpg "GLYZORLLY-MV 0.2")
-Tablets.jpg "GLIMPZY-MP2 SR")
-Tablets-IP.jpg "GLIMPZY-MF1 500SR")
-Tablets.jpg "GLIMPZY-MF1 1000 SR")
-TABLETS.jpg "GLIMPZY-MF2/1000SR")
-Tablets.jpg "GLIMPZY-MP1 SR")
-Tablets-(450-mg-Diosmin-+-50-mg-Hesperidin).jpg "DAFLOFINE 500 mg")
-Tablets.jpg "DAPAGLYFORD-5M FORTE")
-Tablets.jpg "DAPAGLYFORD-M 10/500SR")
-Tablets.jpg "DAPAGLYFORD-10M FORTE")
-Tablets.jpg "DAPAGLYFORD-GM1 XR")
-Tablets.jpg "DAPAGLYFORD-GM2 XR")
-Tablets.jpg "DAPAGLYFORD-M 5/500SR")
-1000-mg-Tablets.jpg "Sitablast DM Forte")
-500-mg-Tablets.jpg "Sitablast DM")
-Tablets.jpg "SITABLAST-M SR 50/500")
-500-mg,-Glimepiride-1-mg-&-Voglibose-0.3-mg-Tablets.jpg "ORLLYMET-GV 1.3 Billyford")
-1000-mg-Tablets.jpg "Tenoliglipt-M 20/1000")
ORLLYFORD